1. Home
  2. SNTI vs BZFD Comparison

SNTI vs BZFD Comparison

Compare SNTI & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • BZFD
  • Stock Information
  • Founded
  • SNTI 2016
  • BZFD 2006
  • Country
  • SNTI United States
  • BZFD United States
  • Employees
  • SNTI N/A
  • BZFD N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • BZFD Movies/Entertainment
  • Sector
  • SNTI Health Care
  • BZFD Consumer Discretionary
  • Exchange
  • SNTI Nasdaq
  • BZFD Nasdaq
  • Market Cap
  • SNTI 53.6M
  • BZFD 64.1M
  • IPO Year
  • SNTI N/A
  • BZFD N/A
  • Fundamental
  • Price
  • SNTI $2.15
  • BZFD $1.61
  • Analyst Decision
  • SNTI Strong Buy
  • BZFD
  • Analyst Count
  • SNTI 3
  • BZFD 0
  • Target Price
  • SNTI $9.67
  • BZFD N/A
  • AVG Volume (30 Days)
  • SNTI 327.7K
  • BZFD 213.7K
  • Earning Date
  • SNTI 11-13-2025
  • BZFD 11-06-2025
  • Dividend Yield
  • SNTI N/A
  • BZFD N/A
  • EPS Growth
  • SNTI N/A
  • BZFD N/A
  • EPS
  • SNTI N/A
  • BZFD 0.25
  • Revenue
  • SNTI N/A
  • BZFD $194,178,000.00
  • Revenue This Year
  • SNTI N/A
  • BZFD $6.87
  • Revenue Next Year
  • SNTI $150.00
  • BZFD $6.21
  • P/E Ratio
  • SNTI N/A
  • BZFD $6.46
  • Revenue Growth
  • SNTI N/A
  • BZFD 1.38
  • 52 Week Low
  • SNTI $1.26
  • BZFD $1.59
  • 52 Week High
  • SNTI $16.94
  • BZFD $5.68
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 62.17
  • BZFD 41.15
  • Support Level
  • SNTI $1.92
  • BZFD $1.59
  • Resistance Level
  • SNTI $2.29
  • BZFD $1.78
  • Average True Range (ATR)
  • SNTI 0.25
  • BZFD 0.08
  • MACD
  • SNTI 0.01
  • BZFD 0.01
  • Stochastic Oscillator
  • SNTI 55.06
  • BZFD 21.05

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About BZFD BuzzFeed Inc.

BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.

Share on Social Networks: